comparemela.com

Latest Breaking News On - Michelle tamir - Page 2 : comparemela.com

Kanabo to Deliver First Medical Grade Cannabis Extract Vape Formulas in the UK

Kanabo to Deliver First Medical Grade Cannabis Extract Vape Formulas in the UK
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Kanabo Appoints Dr Daniel Poulter MP as Non-Executive Director

Kanabo Appoints Dr Daniel Poulter MP as Non-Executive Director
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

Kanabo Group Plc: Kanabo Announces Deal with Greek Cannabis Cultivation Facility

Deal includes commercially attractive rates to be negotiated Raises £1m from investors Kanabo Group Plc, the medicinal cannabis company which recently successfully launched on London Stock Exchange

Investegate |Kanabo Group PLC Announcements | Kanabo Group PLC: Change of Registered Address

Investegate |Kanabo Group PLC Announcements | Kanabo Group PLC: Change of Registered Address
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

Kanabo Group Plc: Newly Listed on LSE, Kanabo Group Announces Partnership With the UK s Biggest Cannabis Clinic Provider, LYPHE Group

(2) Kanabo Group Plc, a medical cannabis company that recently debuted on London Stock Exchange, is delighted to announce it has signed its first UK medicinal cannabis distribution framework agreement with Astral Health Limited ( Astral Health ). Astral Health is fully owned by LYPHE Group, which is part of Drug Science s Project Twenty21. According to the agreement, Kanabo will supply its medical-grade inhalation device, VapePod and a line of medicinal cannabis formulations in pods for the UK market. Through this new framework agreement, it is intended that Kanabo s VapePod medicinal cannabis formula, under brand NOIDECS will be made available to Project Twenty21 patients. Project Twenty21 provides eligible patients with affordable medical cannabis treatment, monitored by Drug Science. The project aims to create the UK s largest body of evidence for the effectiveness and tolerability of medical cannabis.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.